We are live on ! Find out more
ENTX icon

Entera Bio
ENTX

8 hedge funds and large institutions have $7.57M invested in Entera Bio in 2021 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

277% more capital invested

Capital invested by funds: $2.01M → $7.57M (+$5.56M)

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

60% more funds holding

Funds holding: 5 → 8 (+3)

1.82% less ownership

Funds ownership: 10.19% → 8.37% (-1.8%)

Holders
8
Holders Change
+3
Holders Change %
+60%
% of All Funds
0.14%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
5
Increased
3
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
KCM
Knoll Capital Management
Florida
+$115K
2
Renaissance Technologies
Renaissance Technologies
New York
+$111K
3
Millennium Management
Millennium Management
New York
+$88.9K
4
TRCT
Tower Research Capital (TRC)
New York
+$50.6K
5
UBS Group
UBS Group
Switzerland
+$2.63K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$34K
2
PF
Phoenix Financial
Israel
-$14K

ENTX Hedge Fund Activity: Q1 2021 in Review

8 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Entera Bio (ENTX) for Q1 2021, worth a combined $7.57M — up 277% from $2.01M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ENTX positions and 2 closed out — a net gain of 3 holders — while 3 added to existing stakes and 0 trimmed.

The largest buyer was Knoll Capital Management, adding an estimated $115K. The largest seller was Virtu Financial, exiting entirely with an estimated $34K sold.

  • 8 institutional investors held Entera Bio (ENTX) as of Q1 2021, up from 5 in Q4 2020.
  • Funds reported $7.57M of Entera Bio stock for Q1 2021, up 277% quarter-over-quarter.
  • 5 funds opened new Entera Bio positions in Q1 2021 and 2 closed out, a net change of +3 holders.
  • The largest Entera Bio buyer in Q1 2021 was Knoll Capital Management, an estimated $115K added.
  • The largest Entera Bio seller in Q1 2021 was Virtu Financial, an estimated $34K sold.

Based on aggregated 13F filings for Q1 2021.